Patenty

Hřebabecký H., Holý A.:
Method of preparation of 1-(3,5-di-O-benzoyl-2-chloro-2-deoxy-ß-D-threo-pentofuranosyl)thymin
Czech. Appl. 5686-87 (07/29/1987)

Hřebabecký H., Holý A.:
1-(3,5-Di-O-benzouyl-2-deoxy-ß-D-threo-pentofuranosyl)thymin and the method of its preparation
AO 265967 (03/14/1989)

Beránek J., Hřebabecký H., Brokeš J., Novotný L.:
Method of preparation of 5'-chloro-5'-deoxy-5-fluorouridine
AO 264901 (01/12/1989)

Beránek J., Hřebabecký H., Brokeš J., Novotný L.:
Method of preparation of 5'-deoxy-5-fluorouridine
AO 264902 (01/12/1989)

Beránek J., Hřebabecký H., Brokeš J., Novotný L.:
Method of preparation of 5-fluorouridine
AO 264903 (01/12/1989)

Beránek J., Hřebabecký H., Brokeš J., Novotný L.:
Nucleoside derivatives of 6-acetoxy-5-fluoro-5,6-dihydro-uracil and the method of their preparation
AO 264904 (01/12/1989)

Hřebabecký H., Holý A.:
Method of preparation of 1-(3,5-di-O-benzoyl-2-chloro-2-deoxy-ß-D-threo-pentafuranosyl)thymine
AO 274511 (22/12/1992)

Hřebabecký H., Holý A.:
1-(3-Azido-2,3-dideoxy-ß-D-allo-furanosyl)thymin, the method of its preparation and its application
Czech. Appl. 4428-90 (1990)
CS 276874 (1992)

Hřebabecký H., Holý A.:
1-(3,5-di-O-benzoyl-2-chloro-2-deoxy-ß-D-threo-pentafuranosyl)thymine and the method of producing the same
EP 0301908 (09/02/1994)

Dejmek M., Nencka R., Kovačková S., Zborníková E.:
Method of preparation of N9 substituted purine analogues
CZ 305750

Jansa P., Šimon P., Lansdon E., Hu Y. E., Baszczynski O., Dejmek M., Mackman R. L.:
Quinazoline derivatives used to treat HIV
WO 2016/105564

Boura, E., Dubankova, A., Ruzek, D., Eyer, L., Nencka, R.:
Equipment for testing RNA-dependent RNA polymerase inhibitors from the tick-borne encephalitis virus.
CZ32977

Slusher, B., Rojas, C., Thomas, A., Nencka, R., Sala, M., Hrebabecky, H.:
Small Molecule Inhibitors of Neutral Sphingomyelinase 2 (nSMase2) for the Treatment of Neurodegenerative Diseases.
WO2018129405 (Granted)

Birkus, G., Dejmek, M., Nencka, R., Pav, O., Sala, M.:
2'3'-Cyclic dinucleotides comprising carbocyclic nucleotide.
WO2019211799.

Nencka, R., Mejdrova, I., Pavek, P., Dusek, J.:
Selective Ligands of Human Constitutive Androstane Receptor.
WO2020221380 (Granted)

Birkus, G., Brehova, P., Dejmek, M., Nencka, R., Pav, O., Sala, M.:
3'3'-Cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as STING modulator.
WO2020/178768.

Birkus, G., Dejmek, M., Nencka, R., Otava, T., Pav, O., Sala, M.:
3'3' Cyclic dinucleotides with an alkenylene.
WO2022007986. (Granted)

Birkus, G., Dejmek, M. Nencka, R., Sala, M.:
3'3' Cyclic dinucleotides containing isonucleotidic units.
WO2022188903. (Granted)

Kimchi, A., Gilad, Y., Nuta C. G., Nencka R., Brehova, P., Skach K., Boserle, J.:
Inhibitors of Autophagy-Related Protein-Protein Interactions.
WO2023126951

Nencka, R., Otava, T., Dejmek, M., Bouřa, E.:
Nucleoside Derivatives as Antiviral Agents Against Coronaviruses.
EP 23208412.9